Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Clinical trial NCT01602939 · UNKNOWN
Trial details
- NCT number
- NCT01602939
- Sponsor
- Hospital Virgen de la Salud
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2017-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.